Novavax
NVAX
#5380
Rank
C$2.27 B
Marketcap
C$13.83
Share price
2.96%
Change (1 day)
49.83%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): C$0.66 Billion

According to Novavax's latest financial reports the company's current earnings are C$1.08 Billion. , an increase over its 2024 earnings that were of -C$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 C$0.65 B-396.87%
2024 -C$0.23 Billion-70.39%
2023 -C$0.76 Billion-16.59%
2022 -C$0.9 Billion-62.58%
2021 -C$2.41 Billion320.54%
2020 -C$0.58 Billion234.22%
2019 -C$0.18 Billion-30.17%
2018 -C$0.25 Billion1.69%
2017 -C$0.25 Billion-36.44%
2016 -C$0.38 Billion70.4%
2015 -C$0.23 Billion89.27%
2014 -C$0.12 Billion59.83%
2013 -C$73.55 Million81.9%
2012 -C$40.44 Million50.33%
2011 -C$26.9 Million
2009 -C$53.08 Million8.8%
2008 -C$48.79 Million18.01%
2007 -C$41.35 Million18.33%
2006 -C$34.94 Million168.31%
2005 -C$13.03 Million-62.51%
2004 -C$34.74 Million52.4%
2003 -C$22.8 Million-28.21%
2002 -C$31.75 Million
2000 -C$18.1 Million177%
1999 -C$6.54 Million-11.54%
1998 -C$7.39 Million10.64%
1997 -C$6.68 Million-9.62%
1996 -C$7.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
C$22.41 B 3,296.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$15.03 B 2,179.04%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$20.81 B 3,055.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$14.21 B 2,054.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-C$1 Billion-251.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.41 Billion-161.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$29.33 M-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-C$11.54 Million-101.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C$0.37 B-42.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.23 B-64.43%๐Ÿ‡บ๐Ÿ‡ธ USA